Hand sanitizer MRSA-prevention claims unproven

Share this article:

The FDA has issued warning letters to four hand sanitizer manufacturers to cease making claims that its' products prevent methicillin-resistant Staphylococcus aureus infections.

“MRSA is a serious public health threat,” Deborah Autor, director of the Office of Compliance in the FDA's Center for Drug Evaluation and Research, said in a press release. The FDA cannot allow companies to mislead consumers by making unproven prevention claims.”

The following companies and products are in question:

  • Tec Laboratories for Staphaseptic First Aid Antiseptic/Pain Relieving Gel;
  • JD Nelson and Associates for Safe4Hours Hand Sanitizing lotion and Safe4Hours First Aid Antiseptic Skin Protectant;
  • Dr. G.H. Tichenor Antiseptic Co. for Dr. Tichenor's Antiseptic Gel;
  • Oh So Clean, Inc. for CleanWell Hand Sanitizing Wipes and CleanWell All-Natural Antibacterial Foaming Hand Soap.

The FDA said that there is not sufficient evidence to demonstrate that these products effectively prevent MRSA infections, or infections from other bacteria listed on the packaging of some products, including Escherichia coli and influenza A H1N1.

The companies will have 15 days to correct the violations cited in the letters, or face legal action including seizure and injunction.

Consumers should contact their health care provider if a skin infection treated with these products worsens or does not improve. The FDA encourages health care professionals and patients to report adverse events to MedWatch.

Share this article:
You must be a registered member of Clinical Advisor to post a comment.

Next Article in Web Exclusives

More in Web Exclusives

DHEA serum levels predict coronary heart disease risk

DHEA serum levels predict coronary heart disease risk

For elderly men, low serum levels of the adrenal sex hormone DHEA and its sulfate, DHEA-S, predict coronary heart disease risk.

Prenatal exposure to sodium valproate linked to lower IQ in offspring

Prenatal exposure to sodium valproate linked to lower ...

The IQ of children exposed to VPA was lower compared with children born to women without epilepsy and that of those exposed to carbamazepine.

FDA approves first Meningococcal B vaccine

FDA approves first Meningococcal B vaccine

The FDA has approved Trumenba, the first vaccine approved in the U.S. to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B